Wei Dong Liu

Director/Board Member at TOT BIOPHARM INTERNATIONAL COMPANY LIMITED

56 year

Consumer Services

Health Technology

Health Services

Profile

Wei Dong Liu is a non-executive director who currently holds two positions at Tot Biopharm Co. Ltd.
and TOT BIOPHARM International Co. Ltd.
He previously held a non-executive director position at Genetron Holdings Ltd.
Liu earned a doctorate degree from the University of Pittsburgh in 2000 and undergraduate and graduate degrees from Peking University in 1989 and 1994, respectively.

Wei Dong Liu active positions

Companies	Position	Start
TOT BIOPHARM INTERNATIONAL COMPANY LIMITED	Director/Board Member	2023-08-11
Tot Biopharm Co. Ltd. Tot Biopharm Co. Ltd. Pharmaceuticals: MajorHealth Technology Tot Biopharm Co. Ltd. engages in research and development, manufacturing and sales of new drugs. The company was founded on July 5, 2010 and is headquartered in Suzhou, China.	Director/Board Member	2023-08-11

All active positions of Wei Dong Liu

Former positions of Wei Dong Liu

Companies	Position	End
GENETRON HOLDINGS LIMITED	Director/Board Member	-

See the detail of Wei Dong Liu's experience

Training of Wei Dong Liu

University of Pittsburgh	Doctorate Degree
Peking University	Graduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Wei Dong Liu's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
TOT BIOPHARM INTERNATIONAL COMPANY LIMITED	Health Technology

Private companies	2
Tot Biopharm Co. Ltd. Tot Biopharm Co. Ltd. Pharmaceuticals: MajorHealth Technology Tot Biopharm Co. Ltd. engages in research and development, manufacturing and sales of new drugs. The company was founded on July 5, 2010 and is headquartered in Suzhou, China.	Health Technology
Genetron Holdings Ltd. Genetron Holdings Ltd. Medical/Nursing ServicesHealth Services Genetron Holdings, Ltd. engages in precision oncology. It provides cancer molecular profiling by using technologies in molecular biology and data science to transform cancer treatment. It products and services include diagnosis and monitoring through both LDT and IVD products. Its LDT portfolio consists of both specifically designed focused and comprehensive gene panel testing services. It also develops liver cancer early screening products. The company was founded by Si Zhen Wang, Hai Yan, and Wei Wu He in 2015 and is headquartered in Beijing, China.	Health Services